Saturday, 30 March 2024
Agios Pharmaceuticals Inc.
-
Overlay
-
Indicators
-
Settings
-
Period
No Risk Alert Here: Before we dive into any analysis we simply note that Agios Pharmaceuticals Inc (NASDAQ:AGIO) risk is neither elevated nor depressed.
more»
14:07 | 15/3/18
The Lincolnian Online
Agios Pharmaceuticals Inc (NASDAQ:AGIO) - Research analysts at Oppenheimer upped their Q1 2018 earnings per share (EPS) estimates for shares of Agios Pharmaceuticals in a report released on Wednesday, according to Zacks Investment Research.
more»
Price Alert: Agios Pharmaceuticals Inc (NASDAQ:AGIO) has now crossed into technical strength -- watch the technical oscillators for momentum gaps.
more»
16:22 | 14/3/18
StockNewsTimes
Agios Pharmaceuticals (NASDAQ:AGIO) had its price objective hoisted by JPMorgan Chase & Co. from $76.00 to $85.00 in a research note released on Thursday, February 15th.
more»
06:26 | 14/3/18
Nasdaq Journal
Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) closed the previous trading session at $84.52, experiencing a change of 0.68% with 226,050 shares trading hands.
more»
This is a real time view of the critical technical pivot points for Agios Pharmaceuticals Inc (NASDAQ:AGIO) . The technical pivot points we look at all surround the stock price movement from the last 10-trading days through the last year.
more»
01:11 | 14/3/18
Kaplan Herald
Here we will take a look at several key ratios for Agios Pharmaceuticals, Inc. (NasdaqGS:AGIO), starting with the Book to Market (BTM) ratio.
more»
03:41 | 13/3/18
Alpha Beta Stock
U.S. stocks surged on Friday, pushing the Nasdaq composite to a record, after February jobs growth far exceeded expectations. The tech-heavy advanced 1.8 percent to 7,560.81 and hit intraday and closing records, erasing the losses from last month's ...
more»
05:07 | 9/3/18
Post Analyst
ICICI Bank Limited (NYSE:IBN) recorded a trading volume of 13.7 million shares, above its 90-day volume average of 6.69 million shares.
more»
22:56 | 8/3/18
StockNewsTimes
Agios Pharmaceuticals Inc (NASDAQ:AGIO) - Equities researchers at SunTrust Banks issued their Q3 2018 EPS estimates for shares of Agios Pharmaceuticals in a note issued to investors on Thursday, according to Zacks Investment Research.
more»